PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,597 | -36.1% | 21,547 | -48.2% | 0.00% | – |
| Q2 2023 | $47,865 | -0.2% | 41,622 | -8.0% | 0.00% | – |
| Q1 2023 | $47,950 | -89.1% | 45,236 | -84.4% | 0.00% | -100.0% |
| Q4 2022 | $441,302 | -36.4% | 290,330 | -11.3% | 0.00% | 0.0% |
| Q3 2022 | $694,000 | +65.6% | 327,146 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $419,000 | -17.2% | 312,950 | +30.4% | 0.00% | 0.0% |
| Q1 2022 | $506,000 | -75.8% | 240,011 | -57.3% | 0.00% | -50.0% |
| Q4 2021 | $2,088,000 | -1.5% | 562,668 | +32.5% | 0.00% | 0.0% |
| Q3 2021 | $2,120,000 | +129.4% | 424,813 | +199.7% | 0.00% | +100.0% |
| Q2 2021 | $924,000 | +66.8% | 141,750 | +76.4% | 0.00% | 0.0% |
| Q1 2021 | $554,000 | +3593.3% | 80,362 | +1799.4% | 0.00% | – |
| Q3 2020 | $15,000 | – | 4,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |